FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Teligent Pharma Fluocinonide Ointment 0 Recall

Fluocinonide Ointment USP 0

Teligent Pharma, Inc. · Buena, NJ

Risk level
Class III
Reported by FDA
Nov 11, 2020
Recall ID
D-0064-2021
Check your lot numberHow we source this data

Summary

Teligent Pharma recalled Fluocinonide Ointment 0 starting Sep 28, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0064-2021 on Nov 11, 2020. Reason: Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.

Product description

Fluocinonide Ointment USP 0.05%, packaged in: a) 15 gm tube, NDC 52565-0040-15, b) 30 gm tube, NDC 52565-0040-30 c) 60 gram tube, NDC 52565-0040-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310

Lot numbers, UPCs & expiration codes

Lot#: a) 12250, Exp 10/2020; 15039, Exp 1/2022; 15573, Exp 7/2022; b) 12250, Exp 10/2020; 14589, 14848, Exp 12/2021; 15039, Exp 1/2022; 15245, Exp 2/2022; c) 12241, 12249, Exp 10/2020; 14222, Exp 8/2021; 15039, Exp 1/2022; 15037, 15246, Exp 2/2022; 15340, Exp 3/2022; 15387, Exp 4/2022

Where it was sold

United States Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0064-2021
Classification
Class III
Status
Terminated
Recall initiated
Sep 28, 2020
FDA report date
Nov 11, 2020
Quantity
36,790 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Teligent Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0064-2021, exactly as published.

Show all FDA fields
City
Buena
State
NJ
Status
Terminated
Country
United States
Event ID
86508
Address
105 Lincoln Avenue
Code information
Lot#: a) 12250, Exp 10/2020; 15039, Exp 1/2022; 15573, Exp 7/2022; b) 12250, Exp 10/2020; 14589, 14848, Exp 12/2021; 15039, Exp 1/2022; 15245, Exp 2/2022; c) 12241, 12249, Exp 10/2020; 14222, Exp 8/2021; 15039, Exp 1/2022; 15037, 15246, Exp 2/2022; 15340, Exp 3/2022; 15387, Exp 4/2022
Postal code
08310
Report date
Nov 11, 2020
Product type
Drugs
Recall number
D-0064-2021
Classification
Class III
Recalling firm
Teligent Pharma, Inc.
Product quantity
36,790 tubes
Termination date
Aug 22, 2022
Reason for recall
Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fluocinonide Ointment USP 0.05%, packaged in: a) 15 gm tube, NDC 52565-0040-15, b) 30 gm tube, NDC 52565-0040-30 c) 60 gram tube, NDC 52565-0040-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310
Distribution pattern
United States Nationwide
Recall initiation date
Sep 28, 2020
Initial firm notification
Letter
Center classification date
Nov 5, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0064-2021, published Nov 11, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls